October 21, 2024 · 10:51 PM
Within the video under, JP implies that it’s. He’s technically appropriate in that it’s banned in some European nations in response to a January 2024 article at HealthNews. Ozempic and Wegovy are model names for a similar drug: semaglutide, a GLP-1 receptor agonist. Wegovy is FDA-approved for therapy of explicit people with weight problems whereas Ozempic is FDA-approved for therapy of kind 2 diabetes.
I perceive the superficial attraction of drug-induced weight administration: no must idiot with train and dietary restriction.
Steve Parker, M.D.

Filed beneath Medicine for Diabetes, Weight Loss